Fundz

Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer

TAKEN PRIVATEFeb 26, 2025

Position

Chief Financial Officer

Company

Crinetics Pharmaceuticals

Tobin Schilke
tobin.schilke@crinetics.com
San DiegoBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Crinetics Pharmaceuticals, Inc. announced the appointment of Tobin “Toby” Schilke as chief financial officer, effective February 28, 2025.

Quick answer

Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025). Crinetics Pharmaceuticals is based in San Diego, California, United States.

Who is the new Chief Financial Officer at Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals named Tobin Schilke Chief Financial Officer, announced February 26, 2025.
What did Crinetics Pharmaceuticals announce on February 26, 2025?
Crinetics Pharmaceuticals, Inc. announced the appointment of Tobin “Toby” Schilke as chief financial officer, effective February 28, 2025.
What does Crinetics Pharmaceuticals do?
Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors.
Where is Crinetics Pharmaceuticals based?
Crinetics Pharmaceuticals is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Terns Pharmaceuticals (February 25, 2025), Pfizer (February 24, 2025), Bristol Myers Squibb (February 21, 2025) and Santhera Pharmaceuticals (February 10, 2025) also announced leadership changes within 45 days of Crinetics Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Crinetics Pharmaceuticals, and when

A new leader at Crinetics Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Crinetics Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Crinetics Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Crinetics Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Crinetics Pharmaceuticals

Location

San Diego, California, United States

About

Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. Paltusotine, an investigational, first-in-class, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. Crinetics has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894 a first-in-class, investigational, oral ACTH antagonist, that is currently in Phase 2 clinical studies for the treatment of Cushing’s disease and congenital adrenal hyperplasia. All of the Company’s drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including additional discovery programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves’ disease, thyroid eye disease, hyperinsulinism, diabetes and obesity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Crinetics Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Scott
Likely contact at this company
••••••••@••••••••

See Scott's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Crinetics Pharmaceuticals's next move

Learn about Strategic plan

Crinetics Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.